Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Banca Transilvania Group has entered the exchange-traded fund market by launching the BT Index Romania ETF BET-TR, managed by BT Asset Management.
Digi Communications continues to explore strategic options for its Spanish operations, including a potential initial public offering (IPO) of its subsidiary Digi Spain Telecom.
Romania's annual inflation rate will increase and remain at higher levels than previously forecast during March-June 2026, according to the minutes from the National Bank of Romania's monetary policy meeting held in early April.
Millennials aged between 30 and 45 contracted almost two-thirds of mortgage loans processed by Ipotecare.ro in 2025, according to an analysis based on over 1,000 intermediated financings and over 27,000 simulations.
Rețele Electrice Romania, part of the PPC group, has launched a tender worth up to RON 59 million (€12 million) for secondary stations in precast concrete enclosures. The equipment will be used in investment projects between 2026 and 2030.